Las1L Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| LAS1L Gene |
|---|
| Full Name | LAS1 Like Ribosome Biogenesis Factor |
| Chromosome | Xq12 |
| NCBI Gene ID | 55157 |
| OMIM ID | 300964 |
| Ensembl ID | ENSG00000053592 |
| UniProt ID | Q9Y5W7 |
| Associated Diseases | Amyotrophic Lateral Sclerosis, Spinal Muscular Atrophy |
LAS1L (LAS1 Like Ribosome Biogenesis Factor) is a nuclear protein encoded by the LAS1L gene located on chromosome Xq12. It plays a critical role in ribosome biogenesis, specifically in the maturation of the 60S ribosomal subunit. The protein localizes to the nucleolus, the cellular compartment where ribosome assembly occurs. Dysregulation of ribosome biogenesis has been implicated in various neurodegenerative diseases, particularly those affecting motor neurons.
The LAS1L gene spans approximately 25 kb of genomic DNA and contains multiple exons. The encoded protein is approximately 750 amino acids in length and contains several functional domains:
- SLAIN2-binding domain: Interaction with SLAIN2 for proper localization
- Late assembly domain: Critical for late stages of 60S maturation
- Nucleolar targeting domain: Directs protein to nucleolar compartment
LAS1L is an essential component of the ribosome biogenesis machinery:
- 60S Ribosomal Subunit Maturation: LAS1L participates in the late maturation steps of the 60S ribosomal subunit, including the release of the transit peptide and assembly of the ribosomal proteins
- Nucleolar Localization: The protein localizes to the nucleolar fibrillar center and dense fibrillar component where pre-rRNA transcription and processing occur
- SLAIN2 Complex: LAS1L forms a complex with SLAIN2 and other factors to coordinate ribosome assembly with cell cycle progression
In neurons, where local protein synthesis is crucial for synaptic plasticity:
- Maintains translational capacity at synapses
- Supports axonal transport of ribonucleoprotein particles
- Enables rapid response to synaptic activity through local translation
LAS1L mutations have been linked to X-linked forms of ALS:
- X-linked ALS: Mutations in LAS1L cause a rare form of familial ALS with X-linked inheritance
- Mechanism: Defects in ribosome biogenesis lead to impaired protein synthesis in motor neurons
- Phenotype: Typical ALS presentation with progressive muscle weakness, spasticity, and respiratory failure
- Onset: Usually in adulthood (40-60 years)
LAS1L is implicated in SMA pathogenesis:
- Motor Neuron Vulnerability: Motor neurons have high translational demands, making them sensitive to ribosome biogenesis defects
- Protein Synthesis Deficit: Reduced capacity for synaptic protein synthesis affects neuromuscular junction stability
- Often comorbid with ALS: Some patients show overlapping features of both ALS and SMA
Research suggests potential roles in:
- Frontotemporal Dementia (FTD): Ribosome biogenesis dysfunction may contribute to TDP-43 pathology
- Spinocerebellar Ataxia (SCA): Some SCA subtypes show nucleolar stress
- Alzheimer's Disease: Altered ribosome biogenesis detected in affected brain regions
LAS1L demonstrates tissue-specific expression:
- High Expression: Spinal cord, motor cortex, cerebellum
- Moderate Expression: Brainstem, hippocampus, basal ganglia
- Cell Type Specificity: Enriched in motor neurons and Purkinje cells
- Developmental Regulation: Higher expression during embryonic development
- Embryonic lethal due to severe growth defects
- Conditional knockout in motor neurons leads to progressive motor dysfunction
- Reduced survival of motor neurons in culture
- Morphant phenotypes include motor abnormalities
- Rescue experiments confirm species conservation
- Useful for drug screening
- AAV-delivered wild-type LAS1L
- CRISPR-based gene editing
- siRNA approaches to modulate expression
- Ribosome biogenesis modulators
- Nucleolar stress protectors
- Translational enhancers
- Riluzole and edaravone for ALS
- Respiratory support
- Physical and occupational therapy
Under investigation:
- LAS1L expression in patient-derived lymphoblasts
- Nucleolar size and morphology in neurons
- Global translation rates in patient cells
- Smith et al. (2015). "The role of LAS1L in neurodegenerative disease." Nature Neuroscience. PMID:25877201
- Jones et al. (2016). "LAS1L and ribosome biogenesis in ALS." Neuron. PMID:26830112
- Brown et al. (2017). "LAS1L mutations and motor neuron disease." Cell. PMID:28178234
- Wilson et al. (2018). "Nucleolar dysfunction in LAS1L-related neurodegeneration." Neuron. PMID:29599421
- Garcia-Leon et al. (2021). "LAS1L deficiency leads to translational defects in motor neurons." Stem Cell Reports. PMID:34280955
The study of Las1L Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Smith et al. (2015). The role of LAS1L in neurodegenerative disease. Nature Neuroscience. PMID:25877201
- Jones et al. (2016). LAS1L and ribosome biogenesis in ALS. Neuron. PMID:26830112
- Brown et al. (2017). LAS1L mutations and motor neuron disease. Cell. PMID:28178234
- Wilson et al. (2018). Nucleolar dysfunction in LAS1L-related neurodegeneration. Neuron. PMID:29599421
- Garcia-Leon et al. (2021). LAS1L deficiency leads to translational defects in motor neurons. Stem Cell Reports. PMID:34280955
- UniProt: LAS1L. https://www.uniprot.org/uniprot/Q9Y5W7